Drug intelligence / Profile preview

Huangbai Tongqi

Development stage
Unknown
Lead developer
Xi'an Xintong Pharmaceutical Research
Modality
Small Molecules
Administration
Oral
01

Overview

Huangbai Tongqi is a Traditional Chinese Medicine (TCM) granule formulation developed by Xi'an Xintong Pharmaceutical Research Co., Ltd. for the treatment of postoperative gastrointestinal motility disorder (PGID). It is specifically designed to accelerate the recovery of bowel function following abdominal surgery, aiming to reduce the duration of postoperative ileus. The preparation exerts its therapeutic effects through a multifaceted mechanism that includes the modulation of gastrointestinal hormones, such as motilin and gastrin, to stimulate peristalsis, and the reduction of local inflammatory responses (e.g., inhibition of TNF-alpha and IL-6) that typically contribute to gut paralysis after surgical trauma. Huangbai Tongqi is currently undergoing clinical evaluation in China as a modern TCM preparation.

Brand names
Huangbai Tongqi
Other names
Huangbai Tongqi GranulesHuangbai Tongqi Keli黄柏通气颗粒
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)CCK2R (Cholecystokinin 2 Receptor)MLNR (Human motilin receptor)

Beyond the preview

Go deeper on Huangbai Tongqi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huangbai Tongqi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call